Skip to main content

Research Repository

Advanced Search

All Outputs (6)

The red leg dilemma: a scoping review of the challenges of diagnosing lower limb cellulitis (2018)
Journal Article
Patel, M., Kai, J., Lee, S., & Thomas, K. (2019). The red leg dilemma: a scoping review of the challenges of diagnosing lower limb cellulitis. British Journal of Dermatology, 180(5), 993-1000. https://doi.org/10.1111/bjd.17415

Background: Suspected lower limb cellulitis presentations are commonly misdiagnoses, resulting in avoidable antibiotic prescribing or hospital admissions. Understanding the challenges posed in diagnosing cellulitis may help enhance future care. Ob... Read More about The red leg dilemma: a scoping review of the challenges of diagnosing lower limb cellulitis.

Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT (2018)
Journal Article
Santer, M., Rumsby, K., Ridd, M. J., Francis, N. A., Stuart, B., Chorozoglou, M., …Little, P. (2018). Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT. Health Technology Assessment, 22(57), 1-116. https://doi.org/10.3310/hta22570

Plain English Summary Eczema is very common in children and can have a significant impact, causing itching and sleep problems. The main treatments are emollients, which are used to moisturise the skin, and steroid creams or ointments to treat flare-... Read More about Adding emollient bath additives to standard eczema management for children with eczema: the BATHE RCT.

Feasibility of weekly participant‐reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema) (2018)
Journal Article
Stuart, B., Rumsby, K., Santer, M., Ridd, M. J., Francis, N. A., Chorozoglou, M., …Little, P. (2018). Feasibility of weekly participant‐reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema). Trials, 19, Article 582. https://doi.org/10.1186/s13063-018-2962-3

Background: Patient‐reported outcomes measures in clinical trials ensure that evaluations of effectiveness focus on outcomes that are important to patients. In relapsing‐remitting conditions such as eczema, repeated measurements may allow a more accu... Read More about Feasibility of weekly participant‐reported data collection in a pragmatic randomised controlled trial in primary care: experiences from the BATHE trial (Bath Additives for the Treatment of cHildhood Eczema).

Emollient bath additives for the treatment of childhood eczema (BATHE): multi-centre pragmatic parallel group randomised controlled trial of clinical and cost-effectiveness (2018)
Journal Article
Santer, M., Ridd, M. J., Francis, N. A., Stuart, B., Rumsby, K., Chorozoglou, M., …Little, P. (2018). Emollient bath additives for the treatment of childhood eczema (BATHE): multi-centre pragmatic parallel group randomised controlled trial of clinical and cost-effectiveness. BMJ, 361, 1-8. https://doi.org/10.1136/bmj.k1332

Objectives: To determine the clinical and cost-effectiveness of including emollient bath additives in the management of childhood eczema. Trial design: Pragmatic randomised open-label superiority trial with two parallel groups. Setting and recrui... Read More about Emollient bath additives for the treatment of childhood eczema (BATHE): multi-centre pragmatic parallel group randomised controlled trial of clinical and cost-effectiveness.

Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts (2018)
Journal Article
Teasdale, E., Muller, I., Abdullah Sani, A., Thomas, K. S., Stuart, B., & Santer, M. (2018). Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts. BMJ Open, 8(1), 1-7. https://doi.org/10.1136/bmjopen-2017-018652

Objectives: Vitiligo is a relatively common autoimmune condition causing loss of skin pigment. Around 1 in 100 people in the UK develop vitiligo. It can have a significant impact on quality of life for many of those affected. How people access inform... Read More about Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts.